Himachal HC Orders Investigation into Spurious Drugs Production at Baddi Pharma Units
The complaint alleged that medicine Feracrylum API and 1 percent Feracrylum gel, which are homeostatic polymers, were not as per prescribed formula.;
Advertisement
Shimla: Himachal Pradesh High Court on Thursday disposed of a petition that alleged spurious and substandard drugs were being manufactured by many pharma units in Baddi and directed the Drugs Controller to decide the complaint within two weeks.
Themis Medicare Limited in its complaint alleged that despite several complaints of spurious drugs being manufactured in Baddi, no action was being taken, leading to grave risk to the public health.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.